WallStreetZenWallStreetZen

NYSE: ACA
Arcosa Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ACA

Based on 4 analysts offering 12 month price targets for Arcosa Inc.
Min Forecast
$85.00+15.54%
Avg Forecast
$87.50+18.93%
Max Forecast
$90.00+22.33%

Should I buy or sell ACA stock?

Based on 4 analysts offering ratings for Arcosa Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
1 analysts 25%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACA stock forecasts and price targets.

ACA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Stephens & Co.
Top 4%
97
HoldMaintains$87.00+18.25%2023-08-08
DA Davidson
Top 2%
99
Strong BuyMaintains$90.00+22.33%2023-08-07Find out why
Loop Capital
Top 11%
90
Strong BuyMaintains$88.00+19.61%2023-08-07Find out why
Oppenheimer
Top 17%
84
BuyMaintains$85.00+15.54%2023-05-08

1 of 1

Forecast return on equity

Is ACA forecast to generate an efficient return?
Company
6.42%
Industry
19.55%
Market
58.62%
ACA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ACA forecast to generate an efficient return on assets?
Company
4.18%
Industry
6.73%
ACA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ACA revenue growth forecast

How is ACA forecast to perform vs Engineering & Construction companies and vs the US market?
Company
7.78%
Industry
4.04%
Market
7.9%
ACA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACA vs Engineering & Construction Stocks

TickerPricePrice TargetUp/downsideConsensus
ACA$73.57$87.50+18.93%Strong Buy
EXPO$85.67$104.50+21.98%Buy
DY$91.73$119.50+30.27%Strong Buy
MYRG$135.47$147.00+8.51%Buy
STRL$71.66$65.00-9.29%Strong Buy
View Top Engineering & Construction Stocks

Arcosa Stock Forecast FAQ

Is Arcosa Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: ACA) stock is to Strong Buy ACA stock.

Out of 4 analysts, 2 (50%) are recommending ACA as a Strong Buy, 1 (25%) are recommending ACA as a Buy, 1 (25%) are recommending ACA as a Hold, 0 (0%) are recommending ACA as a Sell, and 0 (0%) are recommending ACA as a Strong Sell.

If you're new to stock investing, here's how to buy Arcosa stock.

What is ACA's forecast return on equity (ROE) for 2023-2025?

(NYSE: ACA) forecast ROE is 6.42%, which is considered weak.

What is ACA's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ACA price target, the average ACA price target is $87.50, with the highest ACA stock price forecast at $90.00 and the lowest ACA stock price forecast at $85.00.

On average, Wall Street analysts predict that Arcosa's share price could reach $87.50 by Aug 8, 2024. The average Arcosa stock price prediction forecasts a potential upside of 18.93% from the current ACA share price of $73.57.

What is ACA's forecast return on assets (ROA) for 2023-2025?

(NYSE: ACA) forecast ROA is 4.18%, which is lower than the forecast US Engineering & Construction industry average of 6.73%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.